Logo Beilstein Institut

Novel synthesis of pseudopeptides bearing a difluoromethyl group by Ugi reaction and desulfanylation

  1. ,
  2. and
Shanghai Key Laboratory of Chemical Biology, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China
  1. Corresponding author email
This article is part of the Thematic Series "Multicomponent reactions".
Guest Editor: T. J. J. Müller
Beilstein J. Org. Chem. 2011, 7, 1070–1074. https://doi.org/10.3762/bjoc.7.123
Received 07 Apr 2011, Accepted 12 Jul 2011, Published 08 Aug 2011
Full Research Paper
cc by logo
PDF
Album
Supp Info
Cite

Abstract

Thirteen difluoromethyl-containing pseudopeptides were synthesized by Ugi reaction using the novel building block 2,2-difluoro-2-(phenylthio)acetic acid (2) as one component, followed by removal of the phenylsulfanyl protecting group in the presence of tributyltin hydride and azobisisobutyronitrile.

Keywords: difluoromethyl functionality; gem-difluoromethylene-containing acid; pseudopeptides; reductive cleavage; Ugi reaction

Introduction

Fluorinated amino acids and pseudopeptides have increasingly attracted attention in recent years [1-5]. The selective incorporation of fluorine-containing groups, such as trifluoromethyl, difluoromethyl and difluoromethylene, into peptides or peptidomimetics often drastically alters the chemical, physical, and biological properties of the parent compounds [6-9]. Nowadays, difluoromethyl-containing compounds are increasingly being applied in pharmaceuticals and agrochemicals [10-12]. It is reported that difluoromethyl functionality (CF2H) is isosteric and isopolar to the hydroxyl group and can behave as a hydrogen donor through hydrogen bonding [13].

However, to date, most fluorine-containing peptide modifications involve the introduction of trifluoromethyl or difluoromethylene into molecules [14-18]. Only a few examples have been reported of the preparation and bioassay of pseudopeptides and peptidomimetics bearing difluoromethyl groups. For example, compound I can act as bradykinin B1 antagonist or inverse agonist and can be used in the prevention of inflammation and pain [19]. Compound II is an inhibitor of microsomal triglyceride transfer protein (MTP) and useful for the treatment of obesity and atherosclerosis (Figure 1) [20].

[1860-5397-7-123-1]

Figure 1: Two examples of bioactive pseudopeptides bearing a CF2H group.

Among the protocols for the preparation of pseudopeptide derivatives, the Ugi four-component reaction offers significant advantages over conventional linear-step synthesis [21]. Various fluorinated building blocks have been used in the Ugi four-component reaction to construct a fluorinated compound library [22-25]. Our group has always been interested in developing efficient methods for the preparation of difluoromethyl-containing compounds through multicomponent reactions [26-30]. Recently, we reported a novel and general strategy for the construction of a difluoromethyl compound library, and we further illustrated this strategy by application to the synthesis of CF2H-bearing pseudopeptides and 1,2,3-triazoles through Ugi and click reaction, respectively [27,30]. In continuation of our interest in the synthesis of diverse difluoromethyl-containing pseudopeptides, we herein report a novel and efficient synthesis of difluoromethyl-containing pseudopeptides through Ugi reaction, with gem-difluoromethylene-containing acid as a key component, followed by reductive cleavage of the phenylsulfanyl group (Scheme 1).

[1860-5397-7-123-i1]

Scheme 1: Synthesis of difluoromethyl-containing pseudopeptides (4a–m) by Ugi reaction and desulfanylation.

Results and Discussion

For the purpose of screening novel bioactive compounds, we recently prepared a variety of diverse difluoromethyl-containing pseudopeptides. In our initial experiments, we tried to use difluoroacetic acid as one component to undergo Ugi reaction to prepare difluoromethyl-containing pseudopeptides. Unfortunately, the anticipated difluoromethyl-containing product 4a was not obtained (Scheme 2). Although there are a few examples of acetic acid and trifluoroacetic acid acting as substrates in an Ugi reaction [24,31], up to now, no literature was found concerning the use of difluoroacetic acid as one of the components in the Ugi reaction. For a comparative study, acetic acid and trifluoroacetic acid served as the substrates for the Ugi reaction under the same reaction conditions as those used for the difluoroacetic acid, and the results indicated that the reaction proceeded efficiently regardless of reaction conditions, and the Ugi products (5 and 6) were obtained in good yields. The hydrogen atom next to the CF2 group seems to influence the formation of Ugi product.

[1860-5397-7-123-i2]

Scheme 2: The Ugi reaction of aniline, benzaldehyde, (isocyanomethyl)benzene with acetic acid, difluoroacetic acid and trifluoroacetic acid in methanol or under solvent-free conditions.

In previous studies, we developed a synthetic methodology to prepare functionalized small molecules having a CF2H group [27]. In this work, we first synthesized a protected difluoro-containing building block, 2,2-difluoro-2-(phenylthio)acetic acid (2). The synthesis of compound 2 is illustrated in Scheme 3. The ethyl 2,2-difluoro-2-(phenylthio)acetate (1) was readily prepared by the reaction of ethyl bromodifluoroacetate and thiophenol according to the known procedure [32]. The novel difluorinated acid 2 was obtained by hydrolysis of the ester under basic condition in nearly quantitative yield.

[1860-5397-7-123-i3]

Scheme 3: Synthesis of 2,2-difluoro-2-(phenylthio)acetic acid (2).

After successful synthesis of the protected functionalized CF2 building block 2, we tried to use it as one of the components in the preparations of the difluoromethylene-containing pseudopeptides by Ugi reaction. Indeed, the reaction of aniline, benzaldehyde, (isocyanomethyl)benzene with 2 proceeded efficiently under solvent-free conditions. Finally, we removed the protecting group (PhS) with Bu3SnH/AIBN according to our previous research, and the desired difluoromethyl-containing pseudopeptide was successfully obtained [27].

To demonstrate the scope of the method, several different substituted anilines, substituted benzaldehydes, isocyanides and this novel difluorinated building block 2 were subjected to Ugi reaction under solvent-free conditions, followed by reductive cleavage of the phenylsulfanyl group. It was found that both Ugi reaction and desulfanylation proceeded smoothly for all substrates used to give the corresponding difluoromethylene-containing and difluoromethyl-containing pseudopeptides (3a–m and 4a–m) in good yields (Table 1).

Table 1: Synthesis of difluoromethylene-containing pseudopeptides (3a–m) and difluoromethyl-containing pseudopeptides (4a–m).

[Graphic 1]
Entry R1 R2 R3 3 4
Yield (%)a Yield (%)a
a Ph Ph Bn 82 75
b 2-MePh Ph Bn 78 68
c 2-MePh 4-MePh Bn 75 74
d 4-MeOPh Ph Bn 79 75
e Ph 4-MeOPh Bn 78 70
f 2-MePh 4-MeOPh Bn 74 67
g 4-MePh 4-MeOPh Bn 72 78
h 4-FPh 4-MeOPh Bn 70 71
i Ph 4-FPh Bn 77 75
j 2-MePh 4-FPh Bn 70 69
k 4-MeOPh 4-FPh Bn 72 74
l Ph Ph Ph 68 66
m Ph 4-MeOPh Ph 66 60

aIsolated yield.

Conclusion

In summary, we have developed a novel and efficient protocol for the synthesis of CF2H-containing pseudopeptides by Ugi reaction of substituted anilines, benzaldehyde, isocyanides and the novel building block 2,2-difluoro-2-(phenylthio)acetic acid (2), followed by the cleavage of the phenylsulfanyl group.

Experimental

General

All reagents were of analytic grade, obtained from commercial suppliers and were used without further purification. Melting points were measured in an open capillary using Büchi melting point B-540 apparatus and are uncorrected. 1H NMR and 13C NMR spectra were recorded on a Bruker AM-400 spectrometer (400 MHz and 100 MHz, respectively) using TMS as internal standard. The 19F NMR were obtained using a Bruker AM-400 spectrometer (376 MHz) and the 19F NMR were measured with external CF3CO2H as standard. Gas chromatography-mass spectra (GC-MS) were recorded on HP 5973 MSD with 6890 GC. High resolution mass spectra (HRMS) were recorded under electron impact conditions using a MicroMass GCT CA 055 instrument and recorded on a MicroMass LCTTM spectrometer. Column chromatography was carried out with Merck 60 (230–400 mesh) silica gel.

General procedure for compounds 3a–m

To a stirred amine (1 mmol), the aldehyde (1 mmol) was added in portions for about 5 min. The mixture was stirred for 30 min at rt. Then, the reaction mixture was heated to 60 °C, and isocyanide (1 mmol) and 2,2-difluoro-2-(phenylthio)acetic acid (2) (1 mmol) were added. Stirring was continued at 60 °C for 1 h (TLC). The crude residue was purified by chromatography to give the desired products 3.

General procedure for compounds 4a–m

Bu3SnH (0.58 g, 2 mmol) was added under argon atmosphere to a solution of 3 (1 mmol) in dry toluene (3 mL). Deoxygenation was continued for 5 min. Azobisisobutyronitrile (AIBN) (0.02 g, 0.1 mmol) was added and the solution was heated at reflux for 9 h (TLC). The mixture was concentrated under reduced pressure and the residue was dissolved in EtOAc (5 mL). The solution was stirred with KF/H2O (15 mg/0.15 mL) for 3 h and extracted with EtOAc (3 × 20 mL). The combined organic phases were washed successively with water (20 mL) and brine (20 mL), and dried over anhydrous Na2SO4. After removal of the solvent, the crude product was purified by chromatography to give the desired products 4.

Supporting Information

Supporting Information File 1: Experimental procedures and compound characterization.
Format: PDF Size: 3.9 MB Download

Acknowledgements

We are grateful for financial support from the National Natural Science Foundation of China (Grant No. 21072057), the National Basic Research Program of China (973 Program, 2010CB126101), the Shanghai Foundation of Science and Technology (09391911800) and the Shanghai Leading Academic Discipline Project (B507).

References

  1. Qiu, X.; Meng, W.; Qing, F. Tetrahedron 2004, 60, 6711–6745. doi:10.1016/j.tet.2004.05.051
    Return to citation in text: [1]
  2. Jäckel, C.; Koksch, B. Eur. J. Org. Chem. 2005, 4483–4503. doi:10.1002/ejoc.200500205
    Return to citation in text: [1]
  3. Meng, H.; Kumar, K. J. Am. Chem. Soc. 2007, 129, 15615–15622. doi:10.1021/ja075373f
    Return to citation in text: [1]
  4. Couve-Bonnaire, S.; Cahard, D.; Pannecoucke, X. Org. Biomol. Chem. 2007, 5, 1151–1157. doi:10.1039/b701559c
    Return to citation in text: [1]
  5. Mlostoń, G.; Obijalska, E.; Heimgartner, H. J. Fluorine Chem. 2010, 131, 829–843. doi:10.1016/j.jfluchem.2010.05.014
    Return to citation in text: [1]
  6. Zanda, M. New J. Chem. 2004, 28, 1401–1411. doi:10.1039/B405955G
    Return to citation in text: [1]
  7. Giménez, D.; Andreu, C.; del Olmo, M.; Varea, T.; Diaz, D.; Asensio, G. Bioorg. Med. Chem. 2006, 14, 6971–6978. doi:10.1016/j.bmc.2006.06.027
    Return to citation in text: [1]
  8. Olimpieri, F.; Tambaro, S.; Fustero, S.; Lazzari, P.; Sanchez-Roselló, M.; Pani, L.; Volonterio, A.; Zanda, M. Bioorg. Med. Chem. Lett. 2009, 19, 4715–4719. doi:10.1016/j.bmcl.2009.06.064
    Return to citation in text: [1]
  9. Kitamoto, T.; Marubayashi, S.; Yamazaki, T. Tetrahedron 2008, 64, 1888–1894. doi:10.1016/j.tet.2007.11.085
    Return to citation in text: [1]
  10. Goure, W. F.; Leschinsky, K. L.; Wratten, S. J.; Chupp, J. P. J. Agric. Food Chem. 1991, 39, 981–986. doi:10.1021/jf00005a036
    Return to citation in text: [1]
  11. Ojima, I.; Lin, S.; Slater, J. C.; Wang, T.; Pera, P.; Bernacki, R. J.; Ferlini, C.; Scambia, G. Bioorg. Med. Chem. 2000, 8, 1619–1628. doi:10.1016/S0968-0896(00)00093-6
    Return to citation in text: [1]
  12. Ferreira, S. B.; Costa, M. S.; Boechat, N.; Bezerra, R. J. S.; Genestra, M. S.; Canto-Cavalheiro, M. M.; Kover, W. B.; Ferreira, V. F. Eur. J. Med. Chem. 2007, 42, 1388–1395. doi:10.1016/j.ejmech.2007.02.020
    Return to citation in text: [1]
  13. Erickson, J. A.; McLoughlin, J. I. J. Org. Chem. 1995, 60, 1626–1631. doi:10.1021/jo00111a021
    Return to citation in text: [1]
  14. Formicola, L.; Maréchal, X.; Basse, N.; Bouvier-Durand, M.; Bonnet-Delpon, D.; Milcent, T.; Reboud-Ravaux, M.; Ongeri, S. Bioorg. Med. Chem. Lett. 2009, 19, 83–86. doi:10.1016/j.bmcl.2008.11.012
    Return to citation in text: [1]
  15. Fustero, S.; Chiva, G.; Piera, J.; Sanz-Cervera, J. F.; Volonterio, A.; Zanda, M.; Ramirez de Arellano, C. J. Org. Chem. 2009, 74, 3122–3132. doi:10.1021/jo9001867
    Return to citation in text: [1]
  16. Peng, W.; Zhao, J.; He, P.; Zhu, S. Synlett 2006, 296–300. doi:10.1055/s-2006-926225
    Return to citation in text: [1]
  17. Li, G.; van der Donk, W. A. Org. Lett. 2007, 9, 41–44. doi:10.1021/ol062401a
    Return to citation in text: [1]
  18. Bigotti, S.; Meille, S. V.; Volonterio, A.; Zanda, M. J. Fluorine Chem. 2008, 129, 767–774. doi:10.1016/j.jfluchem.2008.06.018
    Return to citation in text: [1]
  19. Bock, M. G.; Feng, D.; Kuduk, S. Aminocyclopropanecarboxamide derivatives as bradykinin antagonists. Patent WO/2005/085198, Sept 15, 2005.
    Return to citation in text: [1]
  20. Bertinato, P.; Maddux, T. M. Microsomal triglyceride transfer protein inhibitors. Patent WO/2004/056775, July 8, 2004.
    Return to citation in text: [1]
  21. Dömling, A. Chem. Rev. 2006, 106, 17–89. doi:10.1021/cr0505728
    Return to citation in text: [1]
  22. Shibata, N.; Das, B. K.; Takeuchi, Y. J. Chem. Soc., Perkin Trans. 1 2000, 4234–4236. doi:10.1039/b007455l
    Return to citation in text: [1]
  23. Gouge, V.; Jubault, P.; Quirion, J.-C. Tetrahedron Lett. 2004, 45, 773–776. doi:10.1016/j.tetlet.2003.11.019
    Return to citation in text: [1]
  24. Gulevich, A. V.; Shevchenko, N. E.; Balenkova, E. S.; Röschenthaler, G.-V.; Nenajdenko, V. G. Tetrahedron 2008, 64, 11706–11712. doi:10.1016/j.tet.2008.10.004
    Return to citation in text: [1] [2]
  25. Wu, J.; Cao, S. Curr. Org. Chem. 2009, 13, 1791–1804. doi:10.2174/138527209789630460
    Return to citation in text: [1]
  26. Liu, N.; Cao, S.; Shen, L.; Wu, J.; Yu, J.; Zhang, J.; Li, H.; Qian, X. Tetrahedron Lett. 2009, 50, 1982–1985. doi:10.1016/j.tetlet.2009.02.056
    Return to citation in text: [1]
  27. Wu, J.; Cao, S.; Liu, N.; Shen, L.; Yu, J.; Zhang, J.; Li, H.; Qian, X. Org. Biomol. Chem. 2010, 8, 2386–2391. doi:10.1039/c000835d
    Return to citation in text: [1] [2] [3] [4]
  28. Li, H.; Yu, J.; Cao, S.; Shen, L.; Wu, M.; Cheng, J.; Qian, X. Sci. China, Ser. B: Chem. 2010, 53, 1509–1513. doi:10.1007/s11426-010-4005-0
    Return to citation in text: [1]
  29. Wu, M.; Yu, J.; Zhao, W.; Wu, J.; Cao, S. J. Fluorine Chem. 2011, 132, 155–159. doi:10.1016/j.jfluchem.2010.12.010
    Return to citation in text: [1]
  30. Zhang, J.; Wu, J.; Shen, L.; Jin, G.; Cao, S. Adv. Synth. Catal. 2011, 353, 580–584. doi:10.1002/adsc.201000791
    Return to citation in text: [1] [2]
  31. Bouma, M.; Masson, G.; Zhu, J. J. Org. Chem. 2010, 75, 2748–2751. doi:10.1021/jo100302y
    Return to citation in text: [1]
  32. Eto, H.; Kaneko, Y.; Takeda, S.; Tokizawa, M.; Sato, S.; Yoshida, K.; Namiki, S.; Ogawa, M.; Maebashi, K.; Ishida, K.; Matsumoto, M.; Asaoka, T. Chem. Pharm. Bull. 2001, 49, 173–182. doi:10.1248/cpb.49.173
    Return to citation in text: [1]

© 2011 Wu et al; licensee Beilstein-Institut.
This is an Open Access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: (http://www.beilstein-journals.org/bjoc)

Other Beilstein-Institut Open Science Activities
Journal Logo
Institut Logo
Preprint Logo
Symposia Logo